Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants

February 6, 2019 – One of the most important roles we have as a public health agency is educating patients and health care providers about both the benefits and risks of medical products, including breast implants. I know there are many choices of breast implants available to patients, including the size, implant fill and surface texture. We want to provide patients with the most up-to-date information about the variety of breast implants available so that patients and … (leggi tutto)